Lack of a caregiver is associated with shorter survival in myeloma patients undergoing autologous stem cell transplantation.
Morie A GertzRahma WarsameEli MuchtarFrances BuadiAngela DispenzieriWilson GonsalvesDavid DingliSuzanne HaymanPrashant KapoorTaxiarchis KourelisShaji K KumarMartha Q LacyWilliam Joseph HoganPublished in: Leukemia & lymphoma (2022)
There is increasing evidence that social infrastructure and a healthy social network can improve cancer survival. Mayo Clinic has an outpatient stem cell transplantation program for myeloma. Safe outpatient transplantation requires a caregiver to be present. Patients lacking a caregiver are transplanted as an inpatient. We reviewed outcomes on over 2000 patients with multiple myeloma, 2103 transplanted as an outpatient compared with 41 hospitalized for transplantation. Although progression-free survival following transplantation was identical between the two groups, overall survival was shorter in those hospitalized. This suggests that the absence of a caregiver for transplantation is an important surrogate of the social infrastructure associated with poor outcomes in transplanted patients with multiple myeloma.
Keyphrases
- stem cell transplantation
- free survival
- multiple myeloma
- high dose
- mental health
- cell therapy
- newly diagnosed
- healthcare
- patients undergoing
- end stage renal disease
- primary care
- chronic kidney disease
- low dose
- stem cells
- papillary thyroid
- palliative care
- type diabetes
- peritoneal dialysis
- metabolic syndrome
- quality improvement
- adipose tissue
- lymph node metastasis